Prevention of taxane-associated acute pain syndrome with etoricoxib for patients with breast cancer: A phase II randomised trial.

[1]  H. Yamashita,et al.  Risk factor analysis for taxane-associated acute pain syndrome under the dexamethasone prophylaxis , 2021, Supportive Care in Cancer.

[2]  Yuliang Wu,et al.  The protective effects of naproxen against interleukin-1β (IL-1β)- induced damage in human umbilical vein endothelial cells (HUVECs) , 2021, Bioengineered.

[3]  L. Deangelis,et al.  Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy , 2019, Clinical Neurophysiology.

[4]  H. Dosaka-akita,et al.  Efficacy of additional dexamethasone administration for the attenuation of paclitaxel-associated acute pain syndrome , 2019, Supportive Care in Cancer.

[5]  Fen Li,et al.  Interleukin‐1beta released by microglia initiates the enhanced glutamatergic activity in the spinal dorsal horn during paclitaxel‐associated acute pain syndrome , 2018, Glia.

[6]  J. Kirshner,et al.  NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim , 2017, Supportive Care in Cancer.

[7]  B. Hutton,et al.  Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer—a systematic review , 2016, Supportive Care in Cancer.

[8]  Thomas J. Smith,et al.  Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  L. Deangelis,et al.  Electrophysiological Features of Taxane-Induced Polyneuropathy in Patients With Breast Cancer , 2013, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[10]  P. Novotny,et al.  Further data supporting that paclitaxel‐associated acute pain syndrome is associated with development of peripheral neuropathy , 2012, Cancer.

[11]  C. Heckler,et al.  Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  P. Novotny,et al.  Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Friedlander,et al.  Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel‐induced neuropathy , 2011, Muscle and Nerve.

[14]  R. Moore,et al.  Single dose oral etoricoxib for acute postoperative pain in adults. , 2009, The Cochrane database of systematic reviews.

[15]  Tsutomu Yoshida,et al.  The Efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following Carboplatin and Paclitaxel combination chemotherapy for non-small cell lung cancer , 2009, Supportive Care in Cancer.

[16]  S. Curtis,et al.  Etoricoxib versus naproxen in patients with rheumatoid arthritis: a prospective, randomized, comparator-controlled 121-week trial , 2007, Current medical research and opinion.

[17]  J. Reginster,et al.  Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis , 2006, Annals of the rheumatic diseases.

[18]  R. Ettlinger,et al.  Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial , 2004, Scandinavian journal of rheumatology.

[19]  H. Lawrence,et al.  Use of gabapentin in the prevention of taxane-induced arthralgias and myalgias. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  O. Cantoni,et al.  Dexamethasone promotes toxicity in U937 cells exposed to otherwise nontoxic concentrations of peroxynitrite: pivotal role for lipocortin 1-mediated inhibition of cytosolic phospholipase A2. , 2004, Molecular pharmacology.

[21]  P. Novotny,et al.  Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. , 2003, The journal of supportive oncology.

[22]  M. Markman.  Managing taxane toxicities , 2003, Supportive Care in Cancer.

[23]  H. Hoshiai,et al.  Effects of shakuyaku-kanzo-to on muscle pain from combination chemotherapy with paclitaxel and carboplatin. , 2001, Gynecologic oncology.

[24]  M. Gladwin,et al.  Dexamethasone Alters Arachidonate Release from Human Epithelial Cells by Induction of p11 Protein Synthesis and Inhibition of Phospholipase A2 Activity* , 1999, The Journal of Biological Chemistry.

[25]  M. Markman,et al.  Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgias and myalgias. , 1999, Gynecologic oncology.

[26]  E K Rowinsky,et al.  Paclitaxel (taxol) , 1995, The New England journal of medicine.